Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern
Article in Frontiers in Immunology (January 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (January 2024)
Preprint in bioRxiv (May 2023)
Article in Scientific Reports (October 2022)